(Q43868983)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Minoru Yamamoto

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Shoji Ikeda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Hirosato Kondo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

375-378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Peptidyl O-acyl hydroxamates: potent new inactivators of cathepsin B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Matrix metalloproteinases and lysosomal cysteine proteases in osteoclasts contribute to bone resorption through distinct modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

Aspartyl alpha-((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy)methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the P1 and P3 amido nitrogens for enzyme-peptide inhibitor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900755-7

7 January 2021

10.1016/S0960-894X(01)00755-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11814800%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference